1. Home
  2. GNLX vs PROV Comparison

GNLX vs PROV Comparison

Compare GNLX & PROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • PROV
  • Stock Information
  • Founded
  • GNLX 2001
  • PROV 1956
  • Country
  • GNLX United States
  • PROV United States
  • Employees
  • GNLX N/A
  • PROV N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • PROV Savings Institutions
  • Sector
  • GNLX Health Care
  • PROV Finance
  • Exchange
  • GNLX Nasdaq
  • PROV Nasdaq
  • Market Cap
  • GNLX 96.6M
  • PROV 100.7M
  • IPO Year
  • GNLX 2023
  • PROV 1996
  • Fundamental
  • Price
  • GNLX $2.83
  • PROV $15.46
  • Analyst Decision
  • GNLX Strong Buy
  • PROV Hold
  • Analyst Count
  • GNLX 4
  • PROV 1
  • Target Price
  • GNLX $17.75
  • PROV $16.00
  • AVG Volume (30 Days)
  • GNLX 157.9K
  • PROV 4.8K
  • Earning Date
  • GNLX 08-13-2025
  • PROV 07-28-2025
  • Dividend Yield
  • GNLX N/A
  • PROV 3.63%
  • EPS Growth
  • GNLX N/A
  • PROV N/A
  • EPS
  • GNLX N/A
  • PROV 0.97
  • Revenue
  • GNLX N/A
  • PROV $39,909,000.00
  • Revenue This Year
  • GNLX N/A
  • PROV $3.06
  • Revenue Next Year
  • GNLX N/A
  • PROV $9.15
  • P/E Ratio
  • GNLX N/A
  • PROV $15.89
  • Revenue Growth
  • GNLX N/A
  • PROV 1.24
  • 52 Week Low
  • GNLX $1.60
  • PROV $12.01
  • 52 Week High
  • GNLX $5.89
  • PROV $16.70
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 57.73
  • PROV 54.23
  • Support Level
  • GNLX $2.85
  • PROV $15.11
  • Resistance Level
  • GNLX $3.29
  • PROV $15.62
  • Average True Range (ATR)
  • GNLX 0.22
  • PROV 0.32
  • MACD
  • GNLX 0.06
  • PROV -0.02
  • Stochastic Oscillator
  • GNLX 64.74
  • PROV 43.62

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. Through the bank, it is engaged in providing community and mortgage banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The company's business segment is Bank. The Bank's activities include attracting deposits, offering banking services, and originating and purchasing single-family, multi-family, commercial real estate, construction, and other mortgage loans and, to a lesser extent, commercial business and consumer loans held for investment.

Share on Social Networks: